Mohell N - Search Results

1

Pharmacology of polymorphic variants of the human 5-HT1A receptor.

Del Tredici AL, Schiffer HH, Burstein ES, Lameh J, Mohell N, Hacksell U, Brann MR, Weiner DM. Del Tredici AL, et al. Among authors: mohell n. Biochem Pharmacol. 2004 Feb 1;67(3):479-90. doi: 10.1016/j.bcp.2003.09.030. Biochem Pharmacol. 2004. PMID: 15037200

2

Identification of novel selective V2 receptor non-peptide agonists.

Del Tredici AL, Vanover KE, Knapp AE, Bertozzi SM, Nash NR, Burstein ES, Lameh J, Currier EA, Davis RE, Brann MR, Mohell N, Olsson R, Piu F. Del Tredici AL, et al. Among authors: mohell n. Biochem Pharmacol. 2008 Oct 30;76(9):1134-41. doi: 10.1016/j.bcp.2008.08.004. Epub 2008 Aug 12. Biochem Pharmacol. 2008. PMID: 18761325

3

Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954).

Croston GE, Olsson R, Currier EA, Burstein ES, Weiner D, Nash N, Severance D, Allenmark SG, Thunberg L, Ma JN, Mohell N, O'Dowd B, Brann MR, Hacksell U. Croston GE, et al. Among authors: mohell n. J Med Chem. 2002 Nov 7;45(23):4950-3. doi: 10.1021/jm025551+. J Med Chem. 2002. PMID: 12408704

4

The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.

Weiner DM, Meltzer HY, Veinbergs I, Donohue EM, Spalding TA, Smith TT, Mohell N, Harvey SC, Lameh J, Nash N, Vanover KE, Olsson R, Jayathilake K, Lee M, Levey AI, Hacksell U, Burstein ES, Davis RE, Brann MR. Weiner DM, et al. Among authors: mohell n. Psychopharmacology (Berl). 2004 Dec;177(1-2):207-16. doi: 10.1007/s00213-004-1940-5. Epub 2004 Jul 16. Psychopharmacology (Berl). 2004. PMID: 15258717

5

Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.

Liu Y, Yu H, Mohell N, Nordvall G, Lewander T, Hacksell U. Liu Y, et al. Among authors: mohell n. J Med Chem. 1995 Jan 6;38(1):150-60. doi: 10.1021/jm00001a020. J Med Chem. 1995. PMID: 7530773

6

Does the dopamine receptor subtype selectivity of antipsychotic agents provide useful leads for the development of novel therapeutic agents?

Hacksell U, Jackson DM, Mohell N. Hacksell U, et al. Among authors: mohell n. Pharmacol Toxicol. 1995 May;76(5):320-4. doi: 10.1111/j.1600-0773.1995.tb00154.x. Pharmacol Toxicol. 1995. PMID: 7567782 Review.

7

Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.

Yu H, Liu Y, Malmberg A, Mohell N, Hacksell U, Lewander T. Yu H, et al. Among authors: mohell n. Eur J Pharmacol. 1996 May 15;303(3):151-62. doi: 10.1016/0014-2999(96)00051-9. Eur J Pharmacol. 1996. PMID: 8813561

8

Interactions of ligands with active and inactive conformations of the dopamine D2 receptor.

Malmberg A, Mohell N, Backlund Höök B, Johansson AM, Hacksell U, Nordvall G. Malmberg A, et al. Among authors: mohell n. Eur J Pharmacol. 1998 Apr 10;346(2-3):299-307. doi: 10.1016/s0014-2999(98)00047-8. Eur J Pharmacol. 1998. PMID: 9652373

9

Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.

Malmberg A, Nordvall G, Johansson AM, Mohell N, Hacksell U. Malmberg A, et al. Among authors: mohell n. Mol Pharmacol. 1994 Aug;46(2):299-312. Mol Pharmacol. 1994. PMID: 8078492

10

Design, synthesis and evaluation of a PLG tripeptidomimetic based on a pyridine scaffold.

Saitton S, Del Tredici AL, Mohell N, Vollinga RC, Boström D, Kihlberg J, Luthman K. Saitton S, et al. Among authors: mohell n. J Med Chem. 2004 Dec 16;47(26):6595-602. doi: 10.1021/jm049484q. J Med Chem. 2004. PMID: 15588094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters